Keywords: روفامینید; AED; antiepileptic drug; CBZ; carbamazepine; CLB; clobazam; CZP; clonazepam; ESL; eslicarbazepine acetate; GBP; gabapentin; ILAE; International League Against Epilepsy; LCM; lacosamide; LEV; levetiracetam; LTG; Lamotrigine; Na; sodium; OXC; oxcarbazepine;
مقالات ISI روفامینید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: روفامینید; ADAM; advanced dissolution, absorption, and metabolism; AED; antiepileptic drug; AUC; area-under-the-curve; B/P; blood to plasma ratio; BID; twice daily; BMI; body mass index; CBZ; carbamazepine; CLint; intrinsic clearance; CLR; renal clearance; CL; clear
Keywords: روفامینید; Drug-induced agranulocytosis; Rufinamide; Hypersensitivity reactions; Lennox–Gastaut syndrome
Keywords: روفامینید; Rufinamide; Paediatric epilepsy; Lennox–Gastaut syndrome; Epileptic encephalopathy; Focal seizures; Antiepileptic drug interactions
Keywords: روفامینید; Rufinamide; Intractable epilepsy; Atonic; Seizure
Rufinamide, an antiepileptic drug, improves cognition and increases neurogenesis in the aged gerbil hippocampal dentate gyrus via increasing expressions of IGF-1, IGF-1R and p-CREB
Keywords: روفامینید; Aged gerbil; cAMP response element binding protein; Dentate gyrus; Insulin-like growth factor-1; Neurogenesis; Rufinamide;
4-Trichloroacetyl-1,2,3-triazoles: A versatile building block for rapid assessment of carbohydrazides and rufinamide derivatives
Keywords: روفامینید; Triazoles; Carbohydrazides; Rufinamide; Haloformic reactions; Cyclocondensation reactions;
Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study
Keywords: روفامینید; AED; antiepileptic drug; CNS; central nervous system; ELDQOL; Epilepsy and Learning Disabilities Quality of Life scale; LGS; Lennox-Gastaut Syndrome; QoL; quality of life; SD; standard deviation; TEAE; treatment-emergent adverse event; VABS-II; Vineland
Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical data
Keywords: روفامینید; Rufinamide; Dosing; Antiepileptic drug; Lennox-Gastaut syndrome; Epilepsy; AE; adverse event; AED; antiepileptic drug; AUC; area under the curve; BID; twice daily; Cmax; peak plasma concentration; ECG; electrocardiogram; EEG; electroencephalogram; EMA;
Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial
Keywords: روفامینید; Rufinamide; Lennox-Gastaut syndrome; Long-term administration; Safety; Seizure outcome;
Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study
Keywords: روفامینید; Lennox-Gastaut syndrome; Rufinamide; Antiepileptic drug therapy; Randomized study; Pharmacokinetic; safety; Infants; AED; antiepileptic drug; AUC; area under the concentration-time curve; Cav; steady-state exposure; CI; confidence interval; CL/F; appare
New solventless and metal-free synthesis of the antiepileptic drug 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide (Rufinamide) and analogues
Keywords: روفامینید; Rufinamide; 1H-1,2,3-triazoles; Trichloroacetylated enolethers; Benzyl azides; 1,3-Dipolar cycloaddition;
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders
Keywords: روفامینید; Rufinamide; Partial epilepsy; Neuronal migration disorders; Refractory seizures;
In vitro transport assays of rufinamide, pregabalin, and zonisamide by human P-glycoprotein
Keywords: روفامینید; Pgp; ABCB1; MDR1; Rufinamide; Zonisamide; Pregabalin
Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: A randomized double-blind placebo-controlled trial in Japan
Keywords: روفامینید; Rufinamide; Lennox-Gastaut syndrome; Randomized double-blind placebo-controlled trial; Efficacy; Tolerability; Pharmacokinetics;
Effectiveness and tolerability of rufinamide in children and young adults with Lennox-Gastaut syndrome: A single center study in Korea
Keywords: روفامینید; Lennox-Gastaut syndrome; Rufinamide; Antiepileptic drug;
Safe and highly efficient syntheses of triazole drugs using Cu2O nanoparticle in aqueous solutions
Keywords: روفامینید; Cu2O-NP; Azide-alkyne cycloaddition; Aqueous solution; Rufinamide;
Rufinamide for refractory focal seizures: An open-label, multicenter European study
Keywords: روفامینید; Rufinamide; Refractory focal seizures; Cryptogenic; Symptomatic; Adjunctive;
Process modelling, simulation and technoeconomic evaluation of crystallisation antisolvents for the continuous pharmaceutical manufacturing of rufinamide
Keywords: روفامینید; Continuous pharmaceutical manufacturing (CPM); Rufinamide; Process modelling and simulation; Technoeconomic evaluation; Green chemistry;
Liquid chromatography–mass spectrometric determination of rufinamide in low volume plasma samples
Keywords: روفامینید; Antiepileptic drug; Rufinamide; Plasma; Liquid chromatography–tandem mass spectrometry; Validation
Development and validation of a stability indicating RP-HPLC method for the determination of Rufinamide
Keywords: روفامینید; Rufinamide; Reversed-phase HPLC; Isocratic elution; Validation; Stability-indicating
Validated liquid chromatographic method for quantitative determination of Rufinamide active pharmaceutical ingredient form and its impurities
Keywords: روفامینید; Analytical method validation; API; Gradient programme; Rufinamide;
Synthesis of 1H-1,2,3-triazoles—Rufinamide analogs by 1,3-dipolar cycloaddition and eletrocyclization reactions of trifluoroacetyl enolethers under thermal solventless conditions
Keywords: روفامینید; 1,3-Dipolar cycloaddition; 1,2,3-Triazoles; Rufinamide; Electrocyclization, Solvent-free reactions
Epilepsy
Keywords: روفامینید; Epilepsy; Seizures; Antiepileptic drugs; Lacosamide; Rufinamide; Ezogabine/Retigabine; Retigabine; Perampanel; Neurostimulation;
Rufinamide as an adjuvant treatment in children with Lennox-Gastaut syndrome
Keywords: روفامینید; Rufinamide; Lennox-Gastaut syndrome; Child;
First long-term experience with the orphan drug rufinamide in children with myoclonic-astatic epilepsy (Doose syndrome)
Keywords: روفامینید; Myoclonic-astatic epilepsy; Doose syndrome; Children; Long-term experience; Rufinamide
Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: The first Italian prospective study
Keywords: روفامینید; Childhood drug resistant epilepsy; Focal epilepsy; Rufinamide;
Activation of suicidal ideation with adjunctive rufinamide in bipolar disorder
Keywords: روفامینید; Rufinamide; Antiepileptic drugs; Suicidal ideation; Bipolar disorder; Rapid cycling; Treatment refractory; PTSD; Intermittent explosive disorder; Anxiety; Epilepsy; Off-label; Hallucinations; Cognitive dysfunction; Education; Rational polypharmacy;
Rufinamide for the treatment of epileptic spasms
Keywords: روفامینید; Epileptic spasms; Rufinamide; West syndrome; Epilepsy;
Rapid assay of rufinamide in dried blood spots by a new liquid chromatography–tandem mass spectrometric method
Keywords: روفامینید; Rufinamide; Liquid chromatography–tandem mass spectrometry; Epilepsy; Anticonvulsant
Pharmacokinetics, bioavailability, & bioequivalenceOriginal researchBioavailability of Three Rufinamide Oral Suspensions Compared With the Marketed 400-mg Tablet Formulation: Results From a Randomized-Sequence, Open-Label, Four-Period, Four-Sequence Cross
Keywords: روفامینید; bioavailability; bioequivalence; oral; rufinamide; suspension; tablet;
Simultaneous HPLC–UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy
Keywords: روفامینید; Rufinamide; Zonisamide; Antiepileptic drugs; High performance liquid chromatography; Deproteinization; UV detection
Rufinamide in children and adults with Lennox–Gastaut syndrome: First Italian multicenter experience
Keywords: روفامینید; Lennox–Gastaut syndrome; Rufinamide; Orphan drug; Pediatrics; Epilepsy; Drop attacks
A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures
Keywords: روفامینید; Epilepsy; Refractory; Partial onset; Antiepileptic drugs; Rufinamide; Randomized controlled
Cost-utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox–Gastaut Syndrome in the United Kingdom
Keywords: روفامینید; Lennox–Gastaut Syndrome; Drop attack; Quality-adjusted life-years; Cost-effectiveness; Rufinamide
Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: First European experience
Keywords: روفامینید; Rufinamide; Refractory epilepsy; Children; Orphan drug; Partial seizures; Generalized seizures; Lennox–Gastaut syndrome; Dravet syndrome
Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions
Keywords: روفامینید; antiepileptic drugs; brivaracetam; carabersat; carisbamate; DP-valproic acid; drug interactions; eslicarbazepine; fluorofelbamate; fosphenytoin; ganaxolone; lacosamide; losigamone; pharmacokinetics; pregabalin; remacemide; retigabine; rufinamide; safinami
Rufinamide
Keywords: روفامینید; Rufinamide; epilepsy; partial seizures; Lennox-Gastaut syndrome;